<DOC>
	<DOCNO>NCT02371941</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled study oral cromolyn sodium make viscous preparation treatment eosinophilic esophagitis .</brief_summary>
	<brief_title>Oral Cromolyn Sodium Treatment Eosinophilic Esophagitis</brief_title>
	<detailed_description>Eosinophilic esophagitis antigen-mediated allergic disease esophagus characterize symptom gastrointestinal complaint eosinophilic inflammation limit esophagus . Currently , first line therapeutic recommendation include swallow , topical steroid dietary therapy . While work majority patient , limitation . The investigator examine use oral cromolyn sodium treatment condition . This medication non-steroid already approve condition . When take orally , essentially absorb systemically , side effect minimal . There 1 brief , retrospective report use condition suggest work . However , study swallow , topical steroid , may require formulate medication viscous preparation work .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Cromolyn Sodium</mesh_term>
	<criteria>Diagnosis eosinophilic esophagitis Concomitant treatment swallow corticosteroid . Any prior use swallow corticosteroid require 4 week washout period . Pregnancy ( female child bear potential urine pregnancy test do baseline ) . Evidence pathologic eosinophilia location GI tract . Participation another research protocol Reduced Renal Hepatic Function ( subject baseline creatinine liver function panel drawn )</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>